Hormone-dependent spinal leiomyoma

R. E. M. Hekster, Nanno Lambooy, Eylard V. van Hall, Bahjat A. Kazzaz, E.J.C. van Rijssel
In: Surgical Neurology · 1994 · vol. 41(4) , pp. 330–333 · doi:10.1016/0090-3019(94)90185-6 · PMID:8165506 · W2054433987
article OA: closed CC0
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This paper investigates a hormone-dependent spinal leiomyoma, exploring its characteristics and potential underlying mechanisms.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

A 43-year-old woman underwent subtotal removal of a cervical spinal leiomyoma in 1980 and 1981. When her (cyclic) symptoms recurred and tumor growth was demonstrated, she was treated with a synthetic anti-gonadotropic hormone (Danazol; Danatrol) until menopause, when medication could be discontinued without further recurrence of her symptoms or increase in size of the residual tumor.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

References (12)

Source provenance

openalex
last seen: 2026-05-11T06:20:36.346967+00:00
License: CC0 · commercial use OK